BU BME’s BOTLab Highlighted in New York Times
Tech article includes BOTLab’s wearable chemotherapy monitoring probe.
BME Assistant Professor Darren Roblyer and his researchers have created a wearable probe that can monitor, in real-time, if chemotherapy is working on a breast-cancer patient. Roblyer’s Biomedical Optical Technologies Lab (BOTLab) specializes in developing and using new optical technologies to study cancer. The group utilizes a suite of optical technologies to study cancer at the molecular, cellular, and tissue levels. Their long term goal is to personalize cancer therapies through continuous monitoring with label-free and safe optical technologies.
The New York Times cited this research in “Looking to Technology to Avoid Doctors’ Offices and Emergency Rooms”, about the role of new technologies in revolutionizing healthcare.